4//SEC Filing
Pilo Shlomo 4
Accession 0001213900-25-022736
CIK 0001415397other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:10 PM ET
Size
7.3 KB
Accession
0001213900-25-022736
Insider Transaction Report
Form 4
Pilo Shlomo
DirectorChief Executive Officer10% Owner
Transactions
- Award
Warrant to purchase Common Stock
2025-03-02+100,000→ 1,100,000 totalExercise: $1.00Exp: 2026-07-15→ Common Stock (100,000 underlying) - Award
Common Stock
2025-03-02$0.50/sh+200,000$100,000→ 3,983,701 total
Footnotes (1)
- [F1]200,000 shares of Common Stock and 100,000 Warrants to purchase Common Stock of the issuer were acquired by the reporting person for a combined purchase price of $0.50 per share of Common Stock and accompanying Warrant to purchase Common Stock. The Warrants are exercisable immediately and will expire on July 15, 2026.
Documents
Issuer
Raphael Pharmaceutical Inc.
CIK 0001415397
Entity typeother
Related Parties
1- filerCIK 0001903730
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:10 PM ET
- Size
- 7.3 KB